Measurement Is a Capital Access Issue
Most founders treat impact measurement as a compliance obligation — something you do after the check clears, to satisfy a reporting template. That framing is exactly backward, and it is costing companies deals they never know they lost.
The global impact investing market has reached $1.571 trillion in assets under management, per the GIIN's 2024 market sizing report, compounding at 21% annually over the prior six years. The capital is not scarce. The measurement infrastructure to access it is.
The incoming wealth transfer makes this more urgent, not less. Cerulli Associates' December 2024 report projects $124 trillion in assets transferring between generations through 2048. The heirs receiving that wealth are not passive stewards. 97% of millennial investors express interest in sustainable investing, per Morgan Stanley's 2025 Sustainable Signals survey, and 73% of younger investors already hold sustainable assets in their portfolios.
The IRIS+ Catalog: How to Choose Metrics That Actually Signal to Investors
The Global Impact Investing Network maintains IRIS+, the most widely adopted impact measurement framework in institutional practice. It contains more than 600 standardized metrics organized by sector, objective, and impact theme. The breadth is a feature for analysts. For founders, it is a trap.
The mistake most early-stage companies make is adopting too many metrics to look rigorous, then tracking none of them with discipline. An investor reviewing a data room does not want to see a list of forty IRIS+ indicators cited without corresponding baselines, collection methodology, or longitudinal data.
The right approach is selective and strategic. Start by identifying your company's primary impact objective. Then select three to five IRIS+ metrics that most directly capture that change. Metrics should be chosen because you can actually collect the underlying data at reasonable cost, because they are meaningful to the investor segment you are targeting, and because they are comparable to benchmarks that exist in your sector.
A workforce development company, for example, might track PI7476 (number of individuals who received job skills training), PI9226 (number of individuals placed in employment), and OI4060 (wages earned by beneficiaries post-placement). Three metrics. One coherent story. Traceable over time. That is what a values-driven allocator can underwrite.
Output Metrics vs. Outcome Metrics: A Distinction That Determines Credibility
The single most common measurement error in early-stage impact companies is reporting outputs as though they are outcomes. This error does not just weaken reporting — it actively undermines investor confidence in a founder's understanding of their own business.
An output is an activity your company performs or a unit your company delivers: meals served, loans disbursed, trees planted, patients seen. Outputs are measurable and important. They are not evidence of impact. A hospital that sees one million patients per year has produced an enormous output. Whether those patients are healthier as a result is an outcome question, and it requires a different kind of evidence.
Outcome metrics capture the change in conditions for your target population: reduced hospitalizations, improved financial stability, lower carbon emissions per unit of production, increased income. They require a baseline, a measurement interval, and a method for attributing change to your intervention rather than to confounding factors.
At seed and Series A stages, you will not have long-term longitudinal data. That is expected. What sophisticated investors want to see is that you have a coherent methodology for collecting outcome data, that you have established baselines, and that your near-term output metrics are credible proxies for the outcomes you are pursuing.
Theory of Change: The Document Investors Use to Underwrite You
A theory of change is not a slide. It is not a mission statement dressed up with arrows. It is a formal, falsifiable account of how your inputs produce your outputs, how your outputs produce your outcomes, and what assumptions must hold for that chain to function.
Impact investors — whether they are institutional funds, family offices, or next-gen inheritors deploying capital through donor-advised funds — use the theory of change as a diligence instrument. It tells them whether the founder understands the mechanism of their own impact.
A credible theory of change contains four components. First, the inputs: capital deployed, staff time, partnerships, technology. Second, the activities: what your company does with those inputs. Third, the outputs: the direct, measurable products of those activities. Fourth, the outcomes: the changes in conditions, behaviors, or systems that result. It also explicitly names the assumptions embedded at each link in the chain.
The founders who advance through impact-focused due diligence are not the ones with the most sophisticated models. They are the ones who can walk an investor through their theory of change in plain language, name where the evidence is strong, name where it is weak, and articulate how they plan to close the gaps.
The Cost of Not Measuring: Deals That Die in Due Diligence
Impact due diligence has a specific failure mode that founders rarely anticipate. When an investor cannot verify your impact claims, they do not ask for more time. They decline and move to the next opportunity in a market growing at 21% annually with no shortage of deals.
The pattern is consistent. A company reaches term sheet conversations with a mission-aligned investor. The founder has a strong product, defensible unit economics, and a genuine social purpose. Then diligence begins, and the impact officer asks for baseline data on the population served, a description of the measurement methodology, and outcome data from the last twelve to twenty-four months. The founder cannot produce them.
The deal does not proceed. Not because the company lacks merit. Because the investor cannot underwrite a claim they cannot verify. 88% of impact investors report meeting or exceeding their financial return expectations, per the GIIN — which means capital is disciplined, not charitable.
The cost of this failure is not just one missed round. It is the exclusion from an increasingly large and fast-growing segment of the capital markets at precisely the stage where the capital would have the most leverage.
What Institutional-Quality Impact Reporting Looks Like at Seed and Series A
Institutional-quality does not mean large-company-scale. It means rigorous, transparent, and consistent — regardless of the size of the company producing it. At seed and Series A, the bar is not a 60-page impact report. It is evidence that you have built the infrastructure to produce one as the company scales.
At seed stage, a founder should be able to present four things: a written theory of change, a selection of three to five IRIS+ metrics with documented baselines, a description of the data collection process, and a brief narrative connecting the impact logic to the financial model.
At Series A, the expectation escalates. Investors expect to see twelve to twenty-four months of outcome data, not just output data. They expect evidence that the measurement system has been stress-tested. They also expect alignment between what you measure and how you compensate the team, because measurement without accountability is theater.
The values-driven inheritors entering the market through family offices and donor-advised funds are not less sophisticated than institutional investors. Many are advised by professionals with decades of impact due diligence experience. They ask the same questions.
Build the Infrastructure Before You Need It
The founders who successfully raise impact capital at seed and Series A are almost never the ones who built their measurement framework in response to investor demand. They built it because they believed their impact thesis was real and wanted to know whether they were delivering on it.
Start with a theory of change written for internal use, not for a pitch deck. Identify the three outcome metrics that would tell you, without ambiguity, whether your company is doing what you built it to do. Establish baselines before you scale. Build the data collection into your operations so it is not a quarterly scramble.
The $124 trillion wealth transfer is not waiting for the measurement infrastructure to catch up. The values-driven heirs inheriting that capital are already deploying it into companies that can demonstrate, in verifiable terms, what their capital will do.
At Ivystone Capital, we work with founders at every stage of that build. Our sourcing process, our due diligence framework, and our portfolio support are oriented toward exactly this kind of company: mission-driven, operationally serious, and building the measurement infrastructure that turns a compelling thesis into an investable one.
